Mimedx (MDXG) Other Non-Current Assets (2010 - 2026)

Mimedx's (MDXG) quarterly Other Non-Current Assets came in at $6.9 million in Q1 2026, up 557.06% year-on-year from $1.0 million in Q1 2025, and down 5.33% quarter-over-quarter from $7.3 million in Q4 2025.

Mimedx (MDXG) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Mimedx has disclosed Other Non-Current Assets across 16 years of filings, most recently posting $6.9 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $6.9 million, up 557.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (up 557.06% YoY), and the FY2025 annual result was $7.3 million, up 8.37% from the prior year.
  • Other Non-Current Assets came in at $6.9 million for Q1 2026 at Mimedx, down from $7.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $7.3 million in Q4 2025 to a low of $146000.0 in Q2 2023.
  • The 5-year median for Other Non-Current Assets is $1.0 million (2025), against an average of $1.9 million.
  • Across the five-year window, Other Non-Current Assets tumbled 89.01% in 2023 and soared 3174.15% in 2024, its largest moves.
  • Mimedx's Other Non-Current Assets stood at $1.9 million in 2022, then sank by 89.01% to $205000.0 in 2023, then jumped by 3174.15% to $6.7 million in 2024, then climbed by 8.37% to $7.3 million in 2025, then declined by 5.33% to $6.9 million in 2026.
  • The last three Other Non-Current Assets figures came in at $6.9 million (Q1 2026), $7.3 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mimedx 546.28 Mn 386.51 Mn 41.62 Mn 6.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.89 Mn
Dec 31, 2025 7.27 Mn
Sep 30, 2025 2.99 Mn
Jun 30, 2025 990,000.00
Mar 31, 2025 1.05 Mn
Dec 31, 2024 6.71 Mn
Sep 30, 2024 1.18 Mn
Jun 30, 2024 1.24 Mn
Mar 31, 2024 1.25 Mn
Dec 31, 2023 205,000.00
Sep 30, 2023 149,000.00
Jun 30, 2023 146,000.00
Mar 31, 2023 147,000.00
Dec 31, 2022 1.87 Mn
Sep 30, 2022 150,000.00
Jun 30, 2022 164,000.00
Mar 31, 2022 172,000.00
Dec 31, 2021 186,000.00
Sep 30, 2021 270,000.00
Jun 30, 2021 313,000.00